SINT SINTX TECHNOLOGIES INC.

SINTX Technologies to Participate in Sidoti & Company Investor Conference

SINTX Technologies to Participate in Sidoti & Company Investor Conference

SALT LAKE CITY, Utah, Dec. 08, 2025 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), today announced that management will be presenting at Sidoti & Company’s Year End Virtual Investor Conference, held December 10-11, 2025.

Sidoti's Year End Virtual Investor Conference

Dates: December 10-11, 2025

Presentation Date and Time: Wednesday, December 10, 2025 at 3:15 P.M. ET

Webcast:

To schedule a one-on-one meeting with SINTX Technologies’ management team, please email KCSA Strategic Communications at .

To be added to the Sintx Technologies email distribution list, please email with SINT in the subject line.

About SINTX Technologies, Inc.

Headquartered in Salt Lake City, Utah, SINTX Technologies, Inc. (NASDAQ: SINT) is an advanced ceramics company that develops, manufactures, and commercializes silicon nitride biomaterials, composites, devices, and related technologies for medical and other high-value applications.

SINTX Contacts:

Jack Perkins or Maria Hocut

KCSA Strategic Communications

SINTX Technologies, Inc.

801.839.3502



EN
08/12/2025

Underlying

SINTSINTX TECHNOLOGIES INC.

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on SINTX TECHNOLOGIES INC.

 PRESS RELEASE
Free
SINT SINTX TECHNOLOG...

SINTX Technologies Appoints Ryan Elmore President to Lead Channel Expa...

SINTX Technologies Appoints Ryan Elmore President to Lead Channel Expansion of Silicon Nitride Biomaterial Platforms Appointment supports acceleration of revenue opportunities from SiNERGY™ silicon nitride devices and antipathogenic fibrous material technologies SALT LAKE CITY, Utah, Feb. 18, 2026 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), an advanced ceramics and biomaterials company focused on silicon nitride (SiN) solutions for medical and other high-value applications, today announced the appointment of Ryan Elmore as President of SINTX T...

February 18, 2026 1 EN
 PRESS RELEASE
Free
SINT SINTX TECHNOLOG...

SINTX Technologies to Participate in Noble Capital Markets’ Emerging G...

SINTX Technologies to Participate in Noble Capital Markets’ Emerging Growth Virtual Equity Conference on February 4–5 SALT LAKE CITY, Utah, Jan. 29, 2026 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), an advanced ceramics and biomaterials company focused on silicon-nitride-based medical technologies, today announced that its management team will present at the Noble Capital Markets Emerging Growth Virtual Equity Conference, to be held February 4–5, 2026. The Company’s participation comes at an important stage in its evolution, following a period o...

January 29, 2026 1 EN
 PRESS RELEASE
Free
SINT SINTX TECHNOLOG...

SINTX Technologies to Participate in Sidoti & Company Investor Confere...

SINTX Technologies to Participate in Sidoti & Company Investor Conference SALT LAKE CITY, Utah, Dec. 08, 2025 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), today announced that management will be presenting at Sidoti & Company’s Year End Virtual Investor Conference, held December 10-11, 2025. Sidoti's Year End Virtual Investor ConferenceDates: December 10-11, 2025Presentation Date and Time: Wednesday, December 10, 2025 at 3:15 P.M. ETWebcast: To schedule a one-on-one meeting with SINTX Technologies’ management team, please email KCSA Strategic ...

December 8, 2025 1 EN
 PRESS RELEASE
Free
SINT SINTX TECHNOLOG...

シンテックス・テクノロジーズ、AI支援型3Dプリント患者特異的インプラント向け窒化ケイ素-PEEK複合材を製造する供給契約をエボニックと締結

シンテックス・テクノロジーズ、AI支援型3Dプリント患者特異的インプラント向け窒化ケイ素-PEEK複合材を製造する供給契約をエボニックと締結 この画期的な契約により、SiN/PEEKカスタムデバイスの即時生産が可能になる ユタ州ソルトレイクシティ発 , Dec. 02, 2025 (GLOBE NEWSWIRE) -- 先進セラミックスおよびバイオマテリアル企業であるシンテックス・テクノロジーズ (SINTX Technologies, Inc.)(NASDAQ: SINT)(以下「SINTX」または「同社」) は本日、高性能ポリマー分野の世界的リーダーであるエボニック (以下「エボニック」)と供給契約を締結したことを発表した。シンテックスの米国生産施設に既に設置されている設備を用いて生産される、患者特異的インプラントのAI支援付加製造向けに設計された、同社独自の窒化ケイ素-PEEK複合材 (SiN/PEEK) (米国特許第10,806,831号) を製造するために使用される。 本契約に基づき、エボニックは商業規模の生産能力を活用してシンテックスの仕様に準拠したSiN/PEEK複合材を製造し、同社はAI設計による3Dプリント式患者特異的インプラントの製造を直ちに開始できるようになる。 シンテックスでは、脊椎腫瘍切除後の整形外科・脳神経外科腫瘍患者のための椎体置換 (...

December 1, 2025 1 EN
 PRESS RELEASE
Free
SINT SINTX TECHNOLOG...

SINTX Technologies, AI 적용한 3D 프린팅 환자 맞춤형 임플란트 위한 실리콘 나이트라이드–PEEK 복합소재 ...

SINTX Technologies, AI 적용한 3D 프린팅 환자 맞춤형 임플란트 위한 실리콘 나이트라이드–PEEK 복합소재 제조 위해 EVONIK과 계약 체결 SiN/PEEK 맞춤 장비 생산에 즉시 착수할 수 있게 돼 미국 유타주 솔트레이크시티, Dec. 02, 2025 (GLOBE NEWSWIRE) -- 첨단 세라믹과 생체소재 회사인 SINTX Technologies, Inc.(나스닥명: SINT) (이하 “SINTX” 또는 “회사”)가 특허를 획득한 실리콘 나이트라이드-PEEK 복합소재(SiN/PEEK) (미국 특허 제10,806,831호)를 제조하기 위해 고성능 폴리머 분야의 글로벌 선도 기업 Evonik Corporation(“EVONIK”)과 공급 계약을 체결했다. 이 소재는 SINTX의 미국 생산 설비에 이미 설치된 장비를 활용하고 AI를 적용해 생산될 예정인 환자 맞춤형 임플란트의 적층 제조를 위해 설계되었다. 이 계약에 따라 EVONIK은 상업 규모의 생산 역량을 활용해 Sin/PEEK 복합소재를 생산하게 되며, 이에 따라 회사는 AI 설계를 바탕으로 3D 프린팅한 환자 맞춤형 임플란트 제조를 즉시 시작할 수 있게 되었다. SIN...

December 1, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch